International Patent: COMPOSITIONS COMPRISING AN ANTI-ACTRII ANTIBODY, TIRZEPATIDE AND ARGININE AND USES THEREOF FOR THE TREATMENT OF OBESITY, DIABETES, METABOLIC SYNDROME, HYPERGLYCAEMIA

GENEVA, Sept. 7 -- ELI LILLY AND COMPANY filed a patent application (US2026/016958) for “COMPOSITIONS COMPRISING AN ANTI-ACTRII ANTIBODY, TIRZEPATIDE AND ARGININE AND USES THEREOF FOR THE TREATMENT OF OBESITY, DIABETES, METABOLIC SYNDROME, HYPERGLYCAEMIA”. With publication no. WO/2026/183390, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/26

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....